Anti-Diabetic Therapies and Cancer: From Bench to Bedside

Anti-Diabetic Therapies and Cancer: From Bench to Bedside

Diabetes mellitus (DM) is a significant risk factor for various cancers, with the impact of anti-diabetic therapies on cancer progression differing across malignancies. Among these therapies, metformin has gained attention for its potential anti-cancer effects, primarily through modulation of the AM...

Full description

Saved in:
Bibliographic Details
Main Authors: Dimitris Kounatidis, Natalia G. Vallianou, Irene Karampela, Eleni Rebelos, Marina Kouveletsou, Vasileios Dalopoulos, Petros Koufopoulos, Evanthia Diakoumopoulou, Nikolaos Tentolouris, Maria Dalamaga
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Biomolecules
Subjects:
cancer
chronic low-grade inflammation
diabetes mellitus
doxorubicin-induced cardiomyopathy
GLP-1 receptor agonists
immune check point inhibitors
Online Access:https://www.mdpi.com/2218-273X/14/11/1479
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2218-273X/14/11/1479

Similar Items